← Literature

Nutritional and Hormonal Responses to an Oral Secretagogue in Obese Patients

observational • 2004 • ID: 15298931

Low Confidence Observational

Primary source: [Open]

Linked compounds: ibutamoren

Outcomes summary

Clinical study examining the effects of MK-677 (ibutamoren), an oral ghrelin mimetic and growth hormone secretagogue, on IGF-1 levels and related hormonal responses; treatment resulted in significant increases in serum IGF-1 and growth hormone levels, supporting the compound's role in stimulating the growth hormone axis; included assessment of nitrogen balance and metabolic parameters.

Limitations

Observational study design without randomized control; study population and duration may limit generalizability; long-term safety impacts on glucose metabolism and potential oncogenic risk of sustained IGF-1 elevation remain uncertain; dosing and treatment protocols may not reflect real-world usage.

Notes

Primary source: PMID 15298931 (see PubMed link on this page).